跳至主要内容
临床试验/IRCT201506252624N18
IRCT201506252624N18已完成4 期

Comparison between metformine and mejestrol for the treatment of endometrial hyperplasia

Vice chancellor for research ,Iran University of Medical Sciences.0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • ultrasound which confirms endometrial thickening and simple endometrial hyperplasia without atypia in endometrial sampling.
  • exclusion criteria: history of intolerance to metformine or mejestrol; using metformine during previous 6 months; history of hepatic or renal disorders; plasma glucose of less than 60 mg/dl or more than 200 mg/dl ; current using of any medication, any gynecologic neoplasia; using any kind of hormones.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research ,Iran University of Medical Sciences.

相似试验

Treatment of endometrial hyperplasia | 临床试验